Oncology Institute (TOIIW) Competitors $0.23 +0.06 (+34.66%) Closing price 03:58 PM EasternExtended Trading$0.22 -0.01 (-2.17%) As of 04:27 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsInsider TradesSEC FilingsShort InterestTrendsBuy This Stock TOIIW vs. ACONW, AONC, DHACW, FMS, LFMDP, PIIIW, TALKW, VSEE, NTRA, and HIMSShould you be buying Oncology Institute stock or one of its competitors? The main competitors of Oncology Institute include Aclarion (ACONW), American Oncology Network (AONC), Digital Health Acquisition (DHACW), Fresenius Medical Care AG & Co. KGaA (FMS), LifeMD (LFMDP), P3 Health Partners (PIIIW), Talkspace (TALKW), VSee Health (VSEE), Natera (NTRA), and Hims & Hers Health (HIMS). These companies are all part of the "healthcare" industry. Oncology Institute vs. Its Competitors Aclarion American Oncology Network Digital Health Acquisition Fresenius Medical Care AG & Co. KGaA LifeMD P3 Health Partners Talkspace VSee Health Natera Hims & Hers Health Aclarion (NASDAQ:ACONW) and Oncology Institute (NASDAQ:TOIIW) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, media sentiment, analyst recommendations, dividends, profitability, valuation, risk and earnings. Is ACONW or TOIIW more profitable? Company Net Margins Return on Equity Return on Assets AclarionN/A N/A N/A Oncology Institute N/A N/A N/A Does the media refer more to ACONW or TOIIW? In the previous week, Oncology Institute had 1 more articles in the media than Aclarion. MarketBeat recorded 2 mentions for Oncology Institute and 1 mentions for Aclarion. Aclarion's average media sentiment score of 0.00 equaled Oncology Institute'saverage media sentiment score. Company Overall Sentiment Aclarion Neutral Oncology Institute Neutral Which has stronger valuation and earnings, ACONW or TOIIW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAclarion$62.95KN/AN/AN/AN/AOncology Institute$424.38MN/AN/AN/AN/A SummaryOncology Institute beats Aclarion on 2 of the 2 factors compared between the two stocks. Get Oncology Institute News Delivered to You Automatically Sign up to receive the latest news and ratings for TOIIW and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TOIIW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TOIIW vs. The Competition Export to ExcelMetricOncology InstituteMedical Care Facilities IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$1.66B$6.13B$10.76BDividend YieldN/A3.77%5.71%4.83%P/E RatioN/A11.5729.8328.55Price / SalesN/A29.78497.98189.71Price / CashN/A12.3236.6160.67Price / BookN/A2.1212.016.61Net IncomeN/A$58.06M$3.32B$276.82M7 Day Performance108.90%6.72%1.79%2.07%1 Month Performance105.36%4.82%6.28%2.62%1 Year PerformanceN/A54.35%61.12%32.86% Oncology Institute Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TOIIWOncology InstituteN/A$0.23+34.7%N/A+945.0%$0.00$424.38M0.00660News CoverageGap UpHigh Trading VolumeACONWAclarionN/A$0.05-8.7%N/AN/A$0.00$62.95K0.007Positive NewsGap DownAONCAmerican Oncology NetworkN/A$8.65-3.4%N/A+162.8%$0.00$1.34B0.001,520Short Interest ↓DHACWDigital Health AcquisitionN/A$0.02+6.7%N/A-46.3%$0.00N/A0.00N/AGap UpFMSFresenius Medical Care AG & Co. KGaA3.972 of 5 stars$27.01+1.5%$27.80+2.9%+28.0%$0.00$20.63B22.141,384Positive NewsShort Interest ↓LFMDPLifeMDN/A$23.82-0.8%N/A+6.5%$0.00$245.56M0.00230Positive NewsPIIIWP3 Health PartnersN/A$0.01-0.8%N/A-60.3%$0.00$1.46B0.00500Positive NewsGap DownTALKWTalkspaceN/A$0.07-3.9%N/A-68.6%$0.00$202.61M0.00500Positive NewsGap DownVSEEVSee Health3.001 of 5 stars$0.52-13.9%$5.00+865.4%-66.7%$0.00$10.42M0.00N/ANews CoveragePositive NewsAnalyst ForecastShort Interest ↑High Trading VolumeNTRANatera1.8127 of 5 stars$180.54+0.6%$196.81+9.0%+64.3%$24.63B$1.70B-94.524,434Trending NewsAnalyst ForecastInsider TradeShort Interest ↑HIMSHims & Hers Health2.174 of 5 stars$59.12-5.8%$38.92-34.2%+126.9%$14.18B$1.48B73.901,637Analyst ForecastAnalyst RevisionGap Up Related Companies and Tools Related Companies ACONW Alternatives AONC Alternatives DHACW Alternatives FMS Alternatives LFMDP Alternatives PIIIW Alternatives TALKW Alternatives VSEE Alternatives NTRA Alternatives HIMS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TOIIW) was last updated on 10/24/2025 by MarketBeat.com Staff From Our PartnersNext opportunity for crypto millionsThe floodgates have opened. Bitcoin and Ethereum ETFs are seeing record-breaking inflows, the biggest since...Crypto 101 Media | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredElon Musk is on the lineElon Musk says November 6 could "affect the future of the world" Get ready for the biggest pivot in corpora...Altimetry | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | Sponsored$4,200 gold is nice ... but here’s what most gold bugs are missingGold just surged past $4,200, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredTrade this between 9:30 and 10:45 am ESTIf you can be at your computer between 9 a.m. and 10:45 a.m. on most weekdays, I’ll show you a simple trading ...Base Camp Trading | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Oncology Institute, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oncology Institute With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TOIIW Stock Alerts